BACKGROUND: Hyperpigmentation disproportionately affects skin of color, often exacerbated by visible light (VL) exposure. Photoprotection in these populations remains underused due to the cosmetic incompatibility of sunscreens and the lack of targeted education. Iron oxides have emerged as essential VL blockers in tinted sunscreens for hyperpigmentation management. OBJECTIVES: To evaluate the role of iron oxide in tinted sunscreens for hyperpigmentation and assess commercial sunscreen product labeling regarding iron oxide content. METHODS: A literature review was conducted using PubMed and Google Scholar to assess clinical studies on iron oxide for hyperpigmentation. A product analysis of 37 tinted sunscreens was also performed, including ingredient review and direct manufacturer contact regarding iron oxide content. RESULTS: Literature supports that iron oxide-containing sunscreens improve VL-induced pigmentation outcomes. Most products (97.3%) did not list iron oxide as an active ingredient, and only 9.6% of responding brands disclosed iron oxide percentages when contacted, with disclosed concentrations ranging from <1.4% to 10.4%. Although 6 brands (19.3%) claimed their product protects against VL, only one brand publicly detailed any specific corresponding testing performed. CONCLUSION: Iron oxides enhance VL protection in sunscreens for skin prone to hyperpigmentation. Standardized reporting of iron oxide content and/or measurement of VL protection is essential to guide evidence-based photoprotection.
Doan et al. (Wed,) studied this question.